These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 12131300)

  • 21. More extended lymph node dissection template at radical prostatectomy detects metastases in the common iliac region and in the fossa of Marcille.
    Maderthaner L; Furrer MA; Studer UE; Burkhard FC; Thalmann GN; Nguyen DP
    BJU Int; 2018 May; 121(5):725-731. PubMed ID: 28834085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer.
    Wyler SF; Sulser T; Seifert HH; Ruszat R; Forster TH; Gasser TC; Bachmann A
    Urology; 2006 Oct; 68(4):883-7. PubMed ID: 17070376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.
    Häcker A; Jeschke S; Leeb K; Prammer K; Ziegerhofer J; Sega W; Langsteger W; Janetschek G
    J Urol; 2006 Nov; 176(5):2014-8; discussion 2018-9. PubMed ID: 17070241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
    BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying candidates for super-extended staging pelvic lymph node dissection among patients with high-risk prostate cancer.
    Gandaglia G; Zaffuto E; Fossati N; Bandini M; Suardi N; Mazzone E; Dell'Oglio P; Stabile A; Freschi M; Montorsi F; Briganti A
    BJU Int; 2018 Mar; 121(3):421-427. PubMed ID: 29063734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?
    Schumacher MC; Burkhard FC; Thalmann GN; Fleischmann A; Studer UE
    Eur Urol; 2006 Aug; 50(2):272-9. PubMed ID: 16632187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical outcome of radical prostatectomy and pelvic lymph node dissection].
    Mizutani K; Ono Y; Kato N; Takeda A; Yamada S; Kinukawa T; Hattori R; Sahashi M; Matsuura O; Takeuchi N
    Hinyokika Kiyo; 1995 Nov; 41(11):867-71. PubMed ID: 8533688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection.
    Jeschke S; Nambirajan T; Leeb K; Ziegerhofer J; Sega W; Janetschek G
    J Urol; 2005 Jun; 173(6):1943-6. PubMed ID: 15879787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of staging pelvic lymphadenectomy for prostatic cancer.
    Fujioka T; Koike H; Aoki H; Ohhori T; Chiba R; Okamoto S
    Urol Int; 1987; 42(5):380-4. PubMed ID: 3433586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
    Weckermann D; Dorn R; Trefz M; Wagner T; Wawroschek F; Harzmann R
    J Urol; 2007 Mar; 177(3):916-20. PubMed ID: 17296375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limitations of radioguided surgery in high-risk prostate cancer.
    Weckermann D; Dorn R; Holl G; Wagner T; Harzmann R
    Eur Urol; 2007 Jun; 51(6):1549-56; discussion 1556-8. PubMed ID: 16996201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laparoscopic sentinel node dissection for prostate carcinoma: technical and anatomical observations.
    Meinhardt W; Valdés Olmos RA; van der Poel HG; Bex A; Horenblas S
    BJU Int; 2008 Sep; 102(6):714-7. PubMed ID: 18410427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended pelvic lymph node dissection including internal iliac packet should be performed during robot-assisted laparoscopic radical prostatectomy for high-risk prostate cancer.
    Jung JH; Seo JW; Lim MS; Lee JW; Chung BH; Hong SJ; Song JM; Rha KH
    J Laparoendosc Adv Surg Tech A; 2012 Oct; 22(8):785-90. PubMed ID: 22967037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks.
    Tewari A; Narayan P
    J Urol; 1998 Aug; 160(2):430-6. PubMed ID: 9679892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging.
    Jeschke S; Lusuardi L; Myatt A; Hruby S; Pirich C; Janetschek G
    Urology; 2012 Nov; 80(5):1080-6. PubMed ID: 22990053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence Guided Targeted Pelvic Lymph Node Dissection for Intermediate and High Risk Prostate Cancer.
    Hruby S; Englberger C; Lusuardi L; Schätz T; Kunit T; Abdel-Aal AM; Hager M; Janetschek G
    J Urol; 2015 Aug; 194(2):357-63. PubMed ID: 25896557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of High-Risk Prostate Cancer Metastasis to Cloquet's Ilioinguinal Lymph Node.
    Plata Bello A; Apatov SE; Benfante NE; Rivero Belenchón I; Picola Brau N; Mercader Barrull C; Jenjitranant P; Vickers AJ; Fine SW; Touijer KA
    J Urol; 2022 Jun; 207(6):1222-1226. PubMed ID: 35050701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer.
    Jeschke S; Beri A; Grüll M; Ziegerhofer J; Prammer P; Leeb K; Sega W; Janetschek G
    Eur Urol; 2008 Jan; 53(1):126-32. PubMed ID: 17434672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indocyanine Green Guided Pelvic Lymph Node Dissection: An Efficient Technique to Classify the Lymph Node Status of Patients with Prostate Cancer Who Underwent Radical Prostatectomy.
    Ramírez-Backhaus M; Mira Moreno A; Gómez Ferrer A; Calatrava Fons A; Casanova J; Solsona Narbón E; Ortiz Rodríguez IM; Rubio Briones J
    J Urol; 2016 Nov; 196(5):1429-1435. PubMed ID: 27235788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.